Literature DB >> 6978620

Injection sclerotherapy of esophageal varices using ethanolamine oleate.

S E Hedberg, D L Fowler, R L Ryan.   

Abstract

Fifty-three patients with upper gastrointestinal bleeding and proven esophageal varices were treated by intravascular injection sclerotherapy of the varices using a mixture of ethanolamine oleate, bovine thrombin and cephalothin. An intraesophageal balloon was used to impede craniad flow during the injection. Except in three patients who failed to stop bleeding from nonvariceal lesions, sclerotherapy was 94 percent successful in controlling bleeding. The mortality rate in sclerotherapy patients with ascites was 25 percent compared with 54 to 75% reported elsewhere. There has been no rebleeding from varices after the third treatment week in patients followed up for up to 14 months.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6978620     DOI: 10.1016/0002-9610(82)90191-x

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  4 in total

1.  Role of paraoesophageal collaterals and perforating veins on outcome of endoscopic sclerotherapy for oesophageal varices: an endosonographic study.

Authors:  R K Dhiman; G Choudhuri; V A Saraswat; D K Agarwal; S R Naik
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

2.  A clinical controlled trial of endoscopic sclerotherapy for repeated esophageal variceal bleeding.

Authors:  K L Wu; P D Chou; C M Huang; H S Tang; C F Chen; T C Cheng
Journal:  Gastroenterol Jpn       Date:  1989-02

3.  Endoscopic injection sclerotherapy in patients with bleeding esophageal varices: a retrospective analysis.

Authors:  J B Chung; D K Nam; K H Han; W H Kim; D Y Kim; C Y Chon; S I Lee; J K Kang; I S Park; H J Choi
Journal:  Korean J Intern Med       Date:  1990-01       Impact factor: 2.884

4.  A case of noncardiogenic pulmonary edema by ethanolamine oleate.

Authors:  J Y Lee; S H Moon; S M Lee; H T Kim; S Uh; Y H Kim; C S Park
Journal:  Korean J Intern Med       Date:  1994-07       Impact factor: 2.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.